Lux Biosciences, Inc. Report issue

For profit Phase 3 Phase 4
Founded: Jersey City NJ United States (2005)
Status: Defunct (2014)

Organization Overview

First Clinical Trial
2007
NCT00404742
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Chief Medical Officer, Lux Biosciences, Inc. | Luxbiotech